InvestorsHub Logo
Post# of 1030
Next 10
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 09/17/2019 11:10:21 AM

Tuesday, September 17, 2019 11:10:21 AM

Post# of 1030
News: $DRRX DURECT Announces Positive Data from its Phase 2a Clinical Trial of DUR-928 in Alcoholic Hepatitis

CUPERTINO, Calif. , Sept. 17, 2019 /PRNewswire/ --  DURECT Corporation  (Nasdaq: DRRX) today announced that it has completed the Phase 2a clinical trial of its lead product candidate, DUR-928, in patients with alcoholic hepatitis (AH). The final enrollment for the trial consists...

In case you are interested DRRX - DURECT Announces Positive Data from its Phase 2a Clinical Trial of DUR-928 in Alcoholic Hepatitis
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DRRX News